In this session we will explore the journey from bench to bedside, the needs to pass through a complex, heavily regulated environment both for diagnostics and discovery. Also being covered:  

• The journey from bench to bedside needs to pass through a complex, heavily regulated environment, both for diagnostics and discovery 
• Pharma and biotech have an insatiable thirst for data
• Increasing top-down mandates require data sharing both in industry and academia
• There’s value in the secondary use of many different types of datasets, but a huge cost can overwhelm that value if users need to “assemble” them.
• We are launching key improvements and a comprehensive data network to deliver fit-for-purpose, multi-omics, and clinical data to pharmaceutical users.